POLG2

DNA polymerase gamma 2, accessory subunit, the group of DNA polymerases

Basic information

Region (hg38): 17:64477785-64497054

Links

ENSG00000256525NCBI:11232OMIM:604983HGNC:9180Uniprot:Q9UHN1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • mitochondrial DNA depletion syndrome 16 (hepatic type) (Limited), mode of inheritance: AR
  • progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 (Limited), mode of inheritance: AD
  • autosomal dominant progressive external ophthalmoplegia (Supportive), mode of inheritance: AD
  • mitochondrial DNA depletion syndrome (Moderate), mode of inheritance: Semidominant
  • progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4; Mitochondrial DNA depletion syndrome 16; Mitochondrial DNA depletion syndrome 16B (neuroophthalmic type)AD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Gastrointestinal; Musculoskeletal; Neurologic; Ophthalmologic12975295; 15351195; 16685652; 20405137; 22155748; 27592148; 30157269; 31778857

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the POLG2 gene.

  • not_provided (457 variants)
  • not_specified (79 variants)
  • Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions,_autosomal_dominant_4 (37 variants)
  • Hereditary_spastic_paraplegia (14 variants)
  • POLG2-related_disorder (12 variants)
  • Mitochondrial_DNA_depletion_syndrome_16_(hepatic_type) (7 variants)
  • Mitochondrial_dna_depletion_syndrome_16B_(neuroophthalmic_type) (6 variants)
  • Hereditary_skeletal_muscle_disorder (1 variants)
  • Acute_liver_failure (1 variants)
  • Variant_of_unknown_significance (1 variants)
  • Mitochondrial_DNA_depletion_syndrome_16A (1 variants)
  • POLG2-related_spectrum_disorders (1 variants)
  • Progressive_external_ophthalmoplegia_with_mitochondrial_DNA_deletions (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the POLG2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000007215.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
4
clinvar
98
clinvar
1
clinvar
103
missense
1
clinvar
2
clinvar
256
clinvar
21
clinvar
1
clinvar
281
nonsense
6
clinvar
8
clinvar
4
clinvar
18
start loss
3
3
frameshift
14
clinvar
2
clinvar
7
clinvar
23
splice donor/acceptor (+/-2bp)
7
clinvar
2
clinvar
9
Total 21 19 276 119 2

Highest pathogenic variant AF is 0.000046471454

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
POLG2protein_codingprotein_codingENST00000539111 819253
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.53e-100.5831256680801257480.000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3472702541.060.00001223155
Missense in Polyphen8483.4171.0071038
Synonymous-0.34510398.61.040.00000478947
Loss of Function1.321926.30.7210.00000156284

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005390.000539
Ashkenazi Jewish0.00009920.0000992
East Asian0.0001630.000163
Finnish0.0004180.000416
European (Non-Finnish)0.0003870.000378
Middle Eastern0.0001630.000163
South Asian0.0003270.000327
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mitochondrial polymerase processivity subunit. Stimulates the polymerase and exonuclease activities, and increases the processivity of the enzyme. Binds to ss-DNA.;
Disease
DISEASE: Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4) [MIM:610131]: A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. {ECO:0000269|PubMed:16685652}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Mitochondrial biogenesis;Purine metabolism;Pyrimidine metabolism (Consensus)

Recessive Scores

pRec
0.124

Intolerance Scores

loftool
0.383
rvis_EVS
0.09
rvis_percentile_EVS
60.47

Haploinsufficiency Scores

pHI
0.248
hipred
N
hipred_score
0.221
ghis
0.550

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.695

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Polg2
Phenotype
embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cellular phenotype;

Gene ontology

Biological process
in utero embryonic development;DNA replication;DNA-dependent DNA replication;mitochondrial DNA replication;DNA repair;mitochondrion organization;respiratory electron transport chain;mitochondrion morphogenesis;DNA biosynthetic process
Cellular component
mitochondrial chromosome;cytoplasm;mitochondrion;mitochondrial matrix;mitochondrial nucleoid
Molecular function
DNA binding;DNA-directed DNA polymerase activity;protein binding;identical protein binding